The components of an excellent anticoagulation service for patients with AF have been described in 'Excellence in anticoagulant care', developed by NHS London Clinical Networks.1 A checklist for delivering excellence is also available.2
Importantly, excellent anticoagulation services should be patient-centred and directly involve users and carers. All treatment decisions should be made in partnership with patients following a comprehensive education and decision-support consultation, with an ongoing package of patient monitoring, review, education and support.1 As time constraints in general practice often make this a challenge, the following patient leaflet is available to support you in helping your patients to understand more about their condition, treatment options and beyond.
- Patient leaflet for ELIQUIS (apixaban) patients on helping prevent stroke caused by NVAF.
Click here to view ELIQUIS prescribing and adverse event reporting information.
NHS = National Health Service NOAC = Non-VKA Oral Anticoagulant VKA = Vitamin K Antagonist
- London Clinical Networks (NHS). Excellence in anticoagulant care: Defining the elements of an excellent anticoagulation service. August 2016. Available at: http://www.londonscn.nhs.uk/wp-content/uploads/2016/08/stroke-af-anticoag-082016.pdf. Accessed August 2019.
- London Clinical Networks (NHS). Checklist for Delivering Excellence in Anticoagulant Care. Available at: http://www.londonscn.nhs.uk/wp-content/uploads/2017/07/checklist-for-delivering-excellence-in-anticoagulant-care.pdf. Accessed August 2019.
Job code: 432UK1900440-01
Date of preparation: September 2019